Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep 1.
doi: 10.1007/s00210-025-04516-x. Online ahead of print.

Inflammation-related lncRNAs in the regulation of kidney injuries; special emphasis on novel lncRNA-based delivery platforms

Xu Fu  1 , Rawaa Najim Alkhamessi  2 , Raed Fanoukh Aboqader Al-Aouadi  3 , Mustafa Jawad Kadham  4 , Surayyo Khasanova  5 , Mana Shree  6 , Pushkar Jassal  7 , Aashna Sinha  8 , Natrayan Lakshmaiya  9 , ChunYang Wu  10
Affiliations
Review

Inflammation-related lncRNAs in the regulation of kidney injuries; special emphasis on novel lncRNA-based delivery platforms

Xu Fu et al. Naunyn Schmiedebergs Arch Pharmacol. .

Abstract

Long non-coding RNAs (lncRNAs) are distinguished by having a length of over 200 nucleotides and no protein-coding ability. The molecular functions of lncRNAs are diverse and include regulating the activity of small RNAs and proteins, guiding the process of epigenetic alterations, and serving as enhancer RNAs. Moreover, they have a very tissue-specific pattern of expression. These factors already suggest that lncRNAs have a significant function in cellular biology and are involved in development, health, and illness. Moreover, the development and progression of a wide range of complex human illnesses, including kidney-related disease, are fundamentally influenced by the dysregulated expression of various lncRNAs. Since lncRNAs are involved in a number of disease-related processes, including nephron and podocyte injury, inflammation, renal fibrosis, renal vascular changes, transition from acute kidney injury to chronic kidney disease, pyroptosis, apoptosis, and sepsis, they may be potential targets for the next-generation drug development against kidney-related diseases. Therefore, this review comprehensively discusses the most recent research on the molecular mechanisms and therapeutic inferences of several lncRNAs in the pathophysiological context of various kidney injuries through regulating inflammation. Also, considering that lncRNAs have high molecular weight and conserved secondary structure, which makes the delivery of lncRNAs more complicated, we summarize novel lncRNA-based delivery strategies, including LV-, LNP-, and EV-based delivery systems.

Keywords: Delivery of lncRNAs; Diabetic nephropathy; Kidney diseases; LncRNAs; MicroRNAs.

PubMed Disclaimer

Conflict of interest statement

Declarations. Consent for publication: All authors gave final approval of the version to be published and agree to be accountable for all aspects of the work. Competing interests: The authors declare no competing interests.

References

    1. Aboudehen K et al (2018) Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling. J Biol Chem 293(24):9388–9398 - PubMed - PMC
    1. Adams D et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11–21 - PubMed
    1. Agrawal S et al (2018) Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 14(1):57–70 - PubMed
    1. Alexopoulos E et al (2000) Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 15(9):1348–1356 - PubMed
    1. Alvarez ML, DiStefano JK (2011) Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 6(4):e18671 - PubMed - PMC

LinkOut - more resources